title: Pioglitazone and bladder cancer: two studies, same database, two answers.
authors.affiliation: Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre +, Maastricht, the Netherlands; School CAPHRI, Maastricht University, Maastricht, the Netherlands; Department of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
authors.forename: Frank
authors.initials: F
authors.lastname: de Vries
authors.forename: Maurice
authors.initials: M
authors.lastname: Zeegers
authors.forename: Maria E
authors.initials: ME
authors.lastname: Goossens
mesh_terms: D003627:Data Interpretation, Statistical; D016208:Databases, Factual / Q000592:standards* / Q000706:statistics & numerical data; D015340:Epidemiologic Research Design; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects*; D006113:United Kingdom; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000453:epidemiology*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone